0000950170-24-094819.txt : 20240809 0000950170-24-094819.hdr.sgml : 20240809 20240809163514 ACCESSION NUMBER: 0000950170-24-094819 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240808 FILED AS OF DATE: 20240809 DATE AS OF CHANGE: 20240809 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kwon SoYoung CENTRAL INDEX KEY: 0001864406 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37746 FILM NUMBER: 241193376 MAIL ADDRESS: STREET 1: APTEVO THERAPEUTICS INC. STREET 2: 2401 4TH AVENUE, SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aptevo Therapeutics Inc. CENTRAL INDEX KEY: 0001671584 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 811567056 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2401 4TH AVE. STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 206-838-0500 MAIL ADDRESS: STREET 1: 2401 4TH AVE. STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 4 1 ownership.xml 4 X0508 4 2024-08-08 0001671584 Aptevo Therapeutics Inc. APVO 0001864406 Kwon SoYoung 2401 4TH AVENUE SUITE 1050 SEATTLE WA 98121 false true false false SVP, GC, BD & Corp Affairs false Common Stock 2024-08-08 4 M false 213 A 801 D Restricted Stock Unit 2024-08-08 4 M false 213 0 D Common Stock 213 0 D Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis. On August 9, 2022, the reporting person was granted 18,750 (426 post-split) RSUs, vesting in two approximately equal annual installments beginning on August 8, 2023. SoYoung Kwon 2024-08-09